메뉴 건너뛰기




Volumn 39, Issue 2, 2006, Pages 237-243

Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover

Author keywords

Bone mineral density; Bone turnover markers; Osteoporotic fracture; Teriparatide

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE; PARATHYROID HORMONE[1-34]; PROCOLLAGEN C PROTEINASE;

EID: 33744908813     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.02.003     Document Type: Article
Times cited : (79)

References (27)
  • 1
    • 0020509916 scopus 로고
    • Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss
    • Parfitt A.M., Mathews C.H., Villanueva A.R., Kleerekoper M., Frame B., and Rao D.S. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J. Clin. Invest. 72 (1983) 1396-1409
    • (1983) J. Clin. Invest. , vol.72 , pp. 1396-1409
    • Parfitt, A.M.1    Mathews, C.H.2    Villanueva, A.R.3    Kleerekoper, M.4    Frame, B.5    Rao, D.S.6
  • 2
    • 0031689775 scopus 로고    scopus 로고
    • Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial
    • Greenspan S.L., Parker R.A., Ferguson L., Rosen H.N., Maitland-Ramsey L., and Karpf D.B. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J. Bone Miner. Res. 13 (1998) 1431-1438
    • (1998) J. Bone Miner. Res. , vol.13 , pp. 1431-1438
    • Greenspan, S.L.1    Parker, R.A.2    Ferguson, L.3    Rosen, H.N.4    Maitland-Ramsey, L.5    Karpf, D.B.6
  • 3
    • 0032929449 scopus 로고    scopus 로고
    • A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover
    • Garnero P., Darte C., and Delmas P.D. A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover. Bone 24 (1999) 603-609
    • (1999) Bone , vol.24 , pp. 603-609
    • Garnero, P.1    Darte, C.2    Delmas, P.D.3
  • 4
    • 0033306407 scopus 로고    scopus 로고
    • Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study
    • Ravn P., Hosking D., Thompson D., Cizza G., Wasnich R.D., McClung M., et al. Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study. J. Clin. Endocrinol. Metab. 84 (1999) 2363-2368
    • (1999) J. Clin. Endocrinol. Metab. , vol.84 , pp. 2363-2368
    • Ravn, P.1    Hosking, D.2    Thompson, D.3    Cizza, G.4    Wasnich, R.D.5    McClung, M.6
  • 5
    • 0034121540 scopus 로고    scopus 로고
    • Monitoring individual response to hormone replacement therapy with bone markers
    • Delmas P.D., Hardy P., Garnero P., and Dain M. Monitoring individual response to hormone replacement therapy with bone markers. Bone 26 (2000) 553-560
    • (2000) Bone , vol.26 , pp. 553-560
    • Delmas, P.D.1    Hardy, P.2    Garnero, P.3    Dain, M.4
  • 6
    • 0033105942 scopus 로고    scopus 로고
    • Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group
    • Ravn P., Clemmesen B., and Christiansen C. Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group. Bone 24 (1999) 237-244
    • (1999) Bone , vol.24 , pp. 237-244
    • Ravn, P.1    Clemmesen, B.2    Christiansen, C.3
  • 7
    • 0029923080 scopus 로고    scopus 로고
    • Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy
    • Riggs B.L., Melton III L.J., and O'Fallon W.M. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone 18 (1996) 197S-201S
    • (1996) Bone , vol.18
    • Riggs, B.L.1    Melton III, L.J.2    O'Fallon, W.M.3
  • 8
    • 0003062649 scopus 로고    scopus 로고
    • Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density
    • Chesnut III C.H., Bell N.H., Clark G.S., Drinkwater B.L., English S.C., Johnson Jr. C.C., et al. Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am. J. Med. 102 (1997) 29-37
    • (1997) Am. J. Med. , vol.102 , pp. 29-37
    • Chesnut III, C.H.1    Bell, N.H.2    Clark, G.S.3    Drinkwater, B.L.4    English, S.C.5    Johnson Jr., C.C.6
  • 9
    • 0035664686 scopus 로고    scopus 로고
    • Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis
    • Bjarnason N.H., Sarkar S., Duong T., Mitlak B., Delmas P.D., and Christiansen C. Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis. Osteoporos. Int. 12 (2001) 922-930
    • (2001) Osteoporos. Int. , vol.12 , pp. 922-930
    • Bjarnason, N.H.1    Sarkar, S.2    Duong, T.3    Mitlak, B.4    Delmas, P.D.5    Christiansen, C.6
  • 10
    • 0141625900 scopus 로고    scopus 로고
    • Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate
    • Eastell R., Barton I., Hannon R.A., Chines A., Garnero P., and Delmas P.D. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J. Bone Miner. Res. 18 (2003) 1051-1056
    • (2003) J. Bone Miner. Res. , vol.18 , pp. 1051-1056
    • Eastell, R.1    Barton, I.2    Hannon, R.A.3    Chines, A.4    Garnero, P.5    Delmas, P.D.6
  • 11
    • 0842265895 scopus 로고    scopus 로고
    • Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk
    • Reginster J.Y., Sarkar S., Zegels B., Henrotin Y., Bruyere O., Agnusdei D., et al. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk. Bone 34 (2004) 344-351
    • (2004) Bone , vol.34 , pp. 344-351
    • Reginster, J.Y.1    Sarkar, S.2    Zegels, B.3    Henrotin, Y.4    Bruyere, O.5    Agnusdei, D.6
  • 12
    • 2942739433 scopus 로고    scopus 로고
    • Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk
    • Sarkar S., Reginster J.Y., Crans G.C., Diez-Perez A., Pinette K., and Delmas P. Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk. J. Bone Miner. Res. 19 (2004) 394-401
    • (2004) J. Bone Miner. Res. , vol.19 , pp. 394-401
    • Sarkar, S.1    Reginster, J.Y.2    Crans, G.C.3    Diez-Perez, A.4    Pinette, K.5    Delmas, P.6
  • 13
    • 13144306555 scopus 로고    scopus 로고
    • Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial
    • Bauer D.C., Black D.M., Garnero P., Hochberg M., Ott S., Orloff J., et al. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J. Bone Miner. Res. 19 (2004) 1250-1258
    • (2004) J. Bone Miner. Res. , vol.19 , pp. 1250-1258
    • Bauer, D.C.1    Black, D.M.2    Garnero, P.3    Hochberg, M.4    Ott, S.5    Orloff, J.6
  • 14
    • 33744916321 scopus 로고    scopus 로고
    • Pre-treatment bone turnover and fracture efficacy of alendronate: the fracture intervention trial
    • Bauer D.C., Garnero P., Hochberg M., Santora A.C., Delmas P., Ewing S., et al. Pre-treatment bone turnover and fracture efficacy of alendronate: the fracture intervention trial. J. Bone Miner. Res. 18 Suppl 2 (2003) S55
    • (2003) J. Bone Miner. Res. , vol.18 , Issue.SUPPL. 2
    • Bauer, D.C.1    Garnero, P.2    Hochberg, M.3    Santora, A.C.4    Delmas, P.5    Ewing, S.6
  • 15
    • 33744930649 scopus 로고    scopus 로고
    • Ibandronate is highly efficacious in postmenopausal women with high baseline bone turnover rates
    • Chesnut III C.H., Delmas P.D., Christiansen C., Mahoney P., and Schimmer R.C. Ibandronate is highly efficacious in postmenopausal women with high baseline bone turnover rates. Osteoporos. Int. 13 Suppl. 1 (2004) S15
    • (2004) Osteoporos. Int. , vol.13 , Issue.SUPPL. 1
    • Chesnut III, C.H.1    Delmas, P.D.2    Christiansen, C.3    Mahoney, P.4    Schimmer, R.C.5
  • 16
    • 1642397685 scopus 로고    scopus 로고
    • Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate
    • Seibel M.J., Naganathan V., Barton I., and Grauer A. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate. J. Bone Miner. Res. 19 (2004) 323-329
    • (2004) J. Bone Miner. Res. , vol.19 , pp. 323-329
    • Seibel, M.J.1    Naganathan, V.2    Barton, I.3    Grauer, A.4
  • 17
    • 19044364417 scopus 로고    scopus 로고
    • Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis
    • Chen P., Satterwhite J.H., Licata A.A., Lewiecki E.M., Sipos A.A., Misurski D.M., et al. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. J. Bone Miner. Res. 20 (2005) 962-970
    • (2005) J. Bone Miner. Res. , vol.20 , pp. 962-970
    • Chen, P.1    Satterwhite, J.H.2    Licata, A.A.3    Lewiecki, E.M.4    Sipos, A.A.5    Misurski, D.M.6
  • 18
    • 0141684971 scopus 로고    scopus 로고
    • The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis
    • Black D.M., Greenspan S.L., Ensrud K.E., Palermo L., McGowan J.A., Lang T.F., et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N. Engl. J. Med. 349 (2003) 1207-1215
    • (2003) N. Engl. J. Med. , vol.349 , pp. 1207-1215
    • Black, D.M.1    Greenspan, S.L.2    Ensrud, K.E.3    Palermo, L.4    McGowan, J.A.5    Lang, T.F.6
  • 19
    • 0141573538 scopus 로고    scopus 로고
    • Parathyroid hormone plus alendronate-A combination that does not add up
    • Khosla S. Parathyroid hormone plus alendronate-A combination that does not add up. N. Engl. J. Med. 349 (2003) 1277-1279
    • (2003) N. Engl. J. Med. , vol.349 , pp. 1277-1279
    • Khosla, S.1
  • 20
    • 0035837553 scopus 로고    scopus 로고
    • Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
    • Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., and Reginster J.Y. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344 (2001) 1434-1441
    • (2001) N. Engl. J. Med. , vol.344 , pp. 1434-1441
    • Neer, R.M.1    Arnaud, C.D.2    Zanchetta, J.R.3    Prince, R.4    Gaich, G.A.5    Reginster, J.Y.6
  • 21
    • 0027219544 scopus 로고
    • Vertebral fracture assessment using a semiquantitative technique
    • Genant H.K., Wu C.Y., van Kuijk C., and Nevitt M.C. Vertebral fracture assessment using a semiquantitative technique. J. Bone Miner. Res. 8 (1993) 1137-1148
    • (1993) J. Bone Miner. Res. , vol.8 , pp. 1137-1148
    • Genant, H.K.1    Wu, C.Y.2    van Kuijk, C.3    Nevitt, M.C.4
  • 23
    • 15844376474 scopus 로고    scopus 로고
    • Dual X-ray absorptiometry quality control: comparison of visual examination and process-control charts
    • Lu Y., Mathur A.K., Blunt B.A., Gluer C.C., Will A.S., Fuerst T.P., et al. Dual X-ray absorptiometry quality control: comparison of visual examination and process-control charts. J. Bone Miner. Res. 11 (1996) 626-637
    • (1996) J. Bone Miner. Res. , vol.11 , pp. 626-637
    • Lu, Y.1    Mathur, A.K.2    Blunt, B.A.3    Gluer, C.C.4    Will, A.S.5    Fuerst, T.P.6
  • 24
    • 10144251796 scopus 로고    scopus 로고
    • Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study
    • Garnero P., Hausherr E., Chapuy M.C., Marcelli C., Grandjean H., Muller C., et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J. Bone Miner. Res. 11 (1996) 1531-1538
    • (1996) J. Bone Miner. Res. , vol.11 , pp. 1531-1538
    • Garnero, P.1    Hausherr, E.2    Chapuy, M.C.3    Marcelli, C.4    Grandjean, H.5    Muller, C.6
  • 25
    • 0037216436 scopus 로고    scopus 로고
    • The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis
    • Marcus R., Wang O., Satterwhite J., and Mitlak B. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis. J. Bone Miner. Res. 18 (2003) 18-23
    • (2003) J. Bone Miner. Res. , vol.18 , pp. 18-23
    • Marcus, R.1    Wang, O.2    Satterwhite, J.3    Mitlak, B.4
  • 26
    • 0021268975 scopus 로고
    • Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis
    • Brown J.P., Delmas P.D., Malaval L., Edouard C., Chapuy M.C., and Meunier P.J. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1 (1984) 1091-1093
    • (1984) Lancet , vol.1 , pp. 1091-1093
    • Brown, J.P.1    Delmas, P.D.2    Malaval, L.3    Edouard, C.4    Chapuy, M.C.5    Meunier, P.J.6
  • 27
    • 0033982356 scopus 로고    scopus 로고
    • Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study
    • Ross P.D., Kress B.C., Parson R.E., Wasnich R.D., Armour K.A., and Mizrahi I.A. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos. Int. 11 (2000) 76-82
    • (2000) Osteoporos. Int. , vol.11 , pp. 76-82
    • Ross, P.D.1    Kress, B.C.2    Parson, R.E.3    Wasnich, R.D.4    Armour, K.A.5    Mizrahi, I.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.